Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
716
-
Total 13F shares, excl. options
-
245M
-
Shares change
-
-11.4M
-
Total reported value, excl. options
-
$11.8B
-
Value change
-
-$578M
-
Put/Call ratio
-
0.81
-
Number of buys
-
335
-
Number of sells
-
-353
-
Price
-
$48.31
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q2 2025
834 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q2 2025.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 716 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 245M shares
of 1.23B outstanding shares and own 19.94% of the company stock.
Largest 10 shareholders include Dodge & Cox (71.7M shares), Fisher Asset Management, LLC (13.1M shares), BANK OF AMERICA CORP /DE/ (10M shares), Invesco Ltd. (9.19M shares), Capital World Investors (8.35M shares), MORGAN STANLEY (8.26M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (7.28M shares), RAYMOND JAMES FINANCIAL INC (5.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.53M shares), and BlackRock, Inc. (5.47M shares).
This table shows the top 716 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.